These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 39181)

  • 1. Approaching long-term neuroleptic treatment of schizophrenia.
    Hansell N
    JAMA; 1979 Sep; 242(12):1293-4. PubMed ID: 39181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical forms of severe tardive dyskinesia.
    Gardos G; Cole JO; Salomon M; Schniebolk S
    Am J Psychiatry; 1987 Jul; 144(7):895-902. PubMed ID: 2886062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depot neuroleptic therapy: an underutilized treatment option.
    Glazer WM; Kane JM
    J Clin Psychiatry; 1992 Dec; 53(12):426-33. PubMed ID: 1362569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long-term treatment of schizophrenia in the community.
    Rollin HR
    Practitioner; 1982 Jul; 226(1369):1330-3. PubMed ID: 6125936
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacologic features and effects of neuroleptics.
    Seeman MV
    Can Med Assoc J; 1981 Oct; 125(8):821-6. PubMed ID: 6118205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term treatment of tardive dyskinesia.
    Jus A; Jus K; Fontaine P
    J Clin Psychiatry; 1979 Feb; 40(2):72-7. PubMed ID: 33156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depot neuroleptics: side effects and safety.
    Marder SR
    J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):24S-29S. PubMed ID: 2870089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia.
    Johnson DA
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):13-21. PubMed ID: 6143743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schizophrenia.
    Kane JM
    N Engl J Med; 1996 Jan; 334(1):34-41. PubMed ID: 7494570
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroleptics, antiparkinsonian medication, and schizophrenia.
    Am J Psychiatry; 1981 Oct; 138(10):1389-90. PubMed ID: 6117202
    [No Abstract]   [Full Text] [Related]  

  • 11. Intermittent neuroleptic treatment and risk for tardive dyskinesia: Curaçao Extrapyramidal Syndromes Study III.
    van Harten PN; Hoek HW; Matroos GE; Koeter M; Kahn RS
    Am J Psychiatry; 1998 Apr; 155(4):565-7. PubMed ID: 9546009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of long-acting neuroleptics in the treatment of schizophrenia].
    Levine J; Schooler NR; Cassano G
    Encephale; 1979; 5(3):285-90. PubMed ID: 39740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depot neuroleptic therapy: clinical considerations.
    Remington GJ; Adams ME
    Can J Psychiatry; 1995 Apr; 40(3 Suppl 1):S5-11. PubMed ID: 7627927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can chronic neuroleptic treatment promote sleep disturbances in elderly schizophrenic patients?
    Staedt J; Dewes D; Danos P; Stoppe G
    Int J Geriatr Psychiatry; 2000 Feb; 15(2):170-6. PubMed ID: 10679848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and management of tardive dyskinesia.
    Jeste DV; Wyatt RJ
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):14-8. PubMed ID: 2858473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Withdrawal of antiparkinson drugs in long term neuroleptic treatment].
    Lerner J; Blum E; Fuchs I; Grinberg M
    Harefuah; 1978 Oct; 95(8):239-41. PubMed ID: 33879
    [No Abstract]   [Full Text] [Related]  

  • 17. [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
    Sejil I; Oumaya A; Bouguerra C; Mehdi F; Bellaaj R; Gallali S
    Encephale; 2013 May; 39 Suppl 1():S36-41. PubMed ID: 23219594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of neuroleptic-induced movement disorders in chronic schizophrenia inpatients.
    Janno S; Holi M; Tuisku K; Wahlbeck K
    Am J Psychiatry; 2004 Jan; 161(1):160-3. PubMed ID: 14702266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tardive dyskinesia in schizophrenic outpatients: prevalence and significant variables.
    Ezrin-Waters C; Seeman MV; Seeman P
    J Clin Psychiatry; 1981 Jan; 42(1):16-22. PubMed ID: 6109715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches to the problem of preventing hazards of long-term neuroleptic treatment and of avoiding unnecessary drugs.
    Kristjansen P
    Adv Biochem Psychopharmacol; 1980; 24():505-11. PubMed ID: 6105796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.